Cargando…

Post-marketing safety surveillance of sacituzumab govitecan: an observational, pharmacovigilance study leveraging FAERS database

Background and objective: Sacituzumab govitecan (SG), the first antibody-drug conjugate targeting human trophoblast cell-surface antigen 2 (Trop-2), has been approved by the Food and Drug Administration (FDA) for the treatment of advanced or metastatic breast cancer and urothelial cancer. However, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wensheng, Du, Qiong, Guo, Zihan, Ye, Xuan, Liu, Jiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667432/
https://www.ncbi.nlm.nih.gov/pubmed/38027003
http://dx.doi.org/10.3389/fphar.2023.1283247

Ejemplares similares